Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck

T. Kuhnt, A. Sandner, T. Wendt, R. Engenhart-Cabillic, G. Lammering, M. Flentje, G. Grabenbauer, Allison Schreiber, A. Pirnasch, J. Dunst

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2284-2289
JournalAnnals of Oncology
Volume21
Issue number11
DOIs
Publication statusPublished - Nov 2010

Keywords

  • cetuximab
  • cisplatin
  • hyperfractionated-accelerated
  • locally advanced SCCHN
  • radiotherapy

Cite this

Kuhnt, T., Sandner, A., Wendt, T., Engenhart-Cabillic, R., Lammering, G., Flentje, M., Grabenbauer, G., Schreiber, A., Pirnasch, A., & Dunst, J. (2010). Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck. Annals of Oncology, 21(11), 2284-2289. https://doi.org/10.1093/annonc/mdq216